University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
Avatar

2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resistance or Intolerance?

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Jorge Cortés
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Jorge Cortés
0 views
October 23, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
CML and MPNs: Final Frontiers and New Breakthroughs
21:24
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benef…

Feat. J. Tyner
26:24
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resi…

Feat. J. Cortés
25:18
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Ph- MPN: What Are the Potential Benefits and Limitati…

Feat. O. Odenike
21:19
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on BPDCN: Efficacy Analysis of Available Standard Therap…

Feat. N. Pemmaraju